Breast-conserving surgery in locally advanced breast cancer submitted to neoadjuvant chemotherapy. Safety and effectiveness based on ipsilateral breast tumor recurrence and long-term follow-up (2017)
- Authors:
- USP affiliated authors: FOLGUEIRA, MARIA APARECIDA AZEVEDO KOIKE - FM ; BRENTANI, MARIA MITZI - FM
- Unidade: FM
- DOI: 10.6061/clinics/2017(03)02
- Subjects: CO-TERAPIA; ESTUDOS DE COORTES; RECIDIVA LOCAL DE NEOPLASIA; NEOPLASIAS MAMÁRIAS
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
CARRARA, Guilherme Freire Angotti et al. Breast-conserving surgery in locally advanced breast cancer submitted to neoadjuvant chemotherapy. Safety and effectiveness based on ipsilateral breast tumor recurrence and long-term follow-up. Clinics, v. 72, n. 3, p. 134-142, 2017Tradução . . Disponível em: https://doi.org/10.6061/clinics/2017(03)02. Acesso em: 19 abr. 2024. -
APA
Carrara, G. F. A., Scapulatempo-Neto, C., Abrahão-Machado, L. F., Brentani, M. M., Nunes, J. S., Folgueira, M. A. A. K., & Vieira, R. A. da C. (2017). Breast-conserving surgery in locally advanced breast cancer submitted to neoadjuvant chemotherapy. Safety and effectiveness based on ipsilateral breast tumor recurrence and long-term follow-up. Clinics, 72( 3), 134-142. doi:10.6061/clinics/2017(03)02 -
NLM
Carrara GFA, Scapulatempo-Neto C, Abrahão-Machado LF, Brentani MM, Nunes JS, Folgueira MAAK, Vieira RA da C. Breast-conserving surgery in locally advanced breast cancer submitted to neoadjuvant chemotherapy. Safety and effectiveness based on ipsilateral breast tumor recurrence and long-term follow-up [Internet]. Clinics. 2017 ; 72( 3): 134-142.[citado 2024 abr. 19 ] Available from: https://doi.org/10.6061/clinics/2017(03)02 -
Vancouver
Carrara GFA, Scapulatempo-Neto C, Abrahão-Machado LF, Brentani MM, Nunes JS, Folgueira MAAK, Vieira RA da C. Breast-conserving surgery in locally advanced breast cancer submitted to neoadjuvant chemotherapy. Safety and effectiveness based on ipsilateral breast tumor recurrence and long-term follow-up [Internet]. Clinics. 2017 ; 72( 3): 134-142.[citado 2024 abr. 19 ] Available from: https://doi.org/10.6061/clinics/2017(03)02 - Effects of 1,25 (OH)2D3 on molecules involved in cell cycle control in H-RAS transformed mammary cells
- Genes differentially expressed in breast cancer (BC) sample as compared to normal breast tissue from women without cancer
- Expression of vitamin D receptor mRNA in the hippocampal formation of rats submitted to a model of temporal lobe epilepsy induced by pilocarpine
- Correlação clínico-patológica de pacientes com câncer de mama pós-quimioterapia neoadjuvante
- Uninvolved lymph nodes commonly modulated by the presence of breast cancer cells
- Gene expression associated to response to doxorubicin based primary chemotherapy in breast cancer
- Ação da 1,25(OH)D3 em ciclinas D, E e em TGF BETA2 em células mamárias murinas HC11
- Molecular targets of 1,25(OH)2D3 in HC11 normal mouse mammary cell line
- Efeitos da 1,25(OH)2D3 em células luminais mamárias humanas normais ou transformadas com ERB-B2
- Less active vitamin D system in breast cancer patients than normal women
Informações sobre o DOI: 10.6061/clinics/2017(03)02 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
